Advertisement
Advertisement

EWTX

EWTX logo

Edgewise Therapeutics, Inc. Common Stock

35.59
USD
Sponsored
-1.64
-4.41%
Jun 05, 16:00 UTC -4
Closed
exchange

After-Market

36.30

+0.71
+1.99%

EWTX Earnings Reports

Positive Surprise Ratio

EWTX beat 14 of 21 last estimates.

67%

Next Report

Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.50
Implied change from Q1 26 (Revenue/ EPS)
--
/
+8.70%
Implied change from Q2 25 (Revenue/ EPS)
--
/
+47.06%

Edgewise Therapeutics, Inc. Common Stock earnings per share and revenue

On May 07, 2026, EWTX reported earnings of -0.46 USD per share (EPS) for Q1 26, beating the estimate of -0.49 USD, resulting in a 7.33% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -3.81% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 9 analysts forecast an EPS of -0.50 USD, with revenue projected to reach -- USD, implying an increase of 8.70% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Greenwich LifeSciences, Inc.
Report Date
Jun 01, 2026 For Q4 25
Estimate
-$0.32
Actual
-$0.57
Surprise
-77.70%
FAQ
For Q1 2026, Edgewise Therapeutics, Inc. Common Stock reported EPS of -$0.46, beating estimates by 7.33%, and revenue of $0.00, 0% as expectations.
The stock price moved down -3.81%, changed from $36.99 before the earnings release to $35.58 the day after.
The next earning report is scheduled for Aug 05, 2026.
Based on 9 analysts, Edgewise Therapeutics, Inc. Common Stock is expected to report EPS of -$0.50 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement